Clinical Trials of tACS in Psychiatry - DIY tDCS
Transcript of Clinical Trials of tACS in Psychiatry - DIY tDCS
![Page 1: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/1.jpg)
Clinical Trials of tACSin Psychiatry
Flavio FrohlichUniversity of North Carolina - Chapel Hill
Department of PsychiatryDepartment of Cell Biology and Physiology
Department of Biomedical EngineeringDepartment of Neurology
Neuroscience Center
www.facebook.com/FrohlichLabUNC
![Page 2: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/2.jpg)
• UNC owns IP related with FF as the lead inventor.
• UNC has determined the absence of a conflict of interest (COI) for the majority of work presented here and has determined a “COI with administrative considerations” for the clinical trials in the Frohlich Lab.
• FF is the founder, chief scientific officer, and majority owner of Pulvinar Neuro LLC. We provide solutions for transcranial current stimulation research.
• I speak with many companies and have received industry funding from Tal Medical (travel + research).
• I frequently travel and give presentations. I typically receive reimbursement and a stipend.
Conflicts of Interest
![Page 3: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/3.jpg)
RATIONAL DESIGN
TargetValidation
TargetIdentification
TargetEngagement
![Page 4: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/4.jpg)
Brunelin et al. 2012
![Page 5: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/5.jpg)
Frohlich et al. 2016
![Page 6: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/6.jpg)
![Page 7: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/7.jpg)
• Auditory Hallucinations in SCZ• 10Hz-tACS/tDCS/placebo (double
blind)• 20 min bid / 5 days• 24 pts• Primary: AHRS• Target Engagement: hdEEG
![Page 8: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/8.jpg)
• Major depressive disorder• 10Hz-tACS/40Hz-tACS/placebo
(double blind)• 40 min qd / 5 days• 30 pts• Primary: MADRS (4 week follow
up)• Target Engagement: hdEEG
Angel Peterchev
![Page 9: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/9.jpg)
Our Experience
SafetyFeasibility
Technology
![Page 10: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/10.jpg)
0%10%20%30%40%50%60%70%80%90%
100%
StimulationQuestionnaireResults
Severe
Moderate
Mild
Absent
![Page 11: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/11.jpg)
Device Technology
SafetyPlacebo StimulationEffective BlindingQuality Control
![Page 12: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/12.jpg)
![Page 13: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/13.jpg)
The Future?
…is here?
![Page 14: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/14.jpg)
Premenstrual dysphoric disorder (crossover, 10Hz tACS, placebo).
Post-traumatic stress disorder (10Hz tACS, placebo).
![Page 15: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/15.jpg)
Lustenberger et al. 2016
![Page 16: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/16.jpg)
Lustenberger et al. 2016
![Page 17: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/17.jpg)
Lustenberger et al. 2016
![Page 18: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/18.jpg)
Lustenberger et al. 2016
![Page 19: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/19.jpg)
![Page 20: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/20.jpg)
![Page 21: Clinical Trials of tACS in Psychiatry - DIY tDCS](https://reader031.fdocuments.in/reader031/viewer/2022020701/61f8608c601b1e1b3a21dcfb/html5/thumbnails/21.jpg)
Charles ZhouCaroline LustenbergerSankar AlagapanYuhui LiGuoshi LiEhsan NegahbaniJuliann MellinCourtney LugoMorgan AlexanderPhilipp LustenbergerIain StittSupritha DugyalaToheed KhanQuique TolozaNadia MishalMia DeMarcoMatt MattoniJhana ParikhHemanth AmbalaFlorian SchertenleibCarolyn RappAlexandra VossenFranz HamiltonJessica PageMaadhurya Duvvuri
Alumni Lab MembersMohsin AliKristin SellersKatrina KutchkoStephen SchmidtChunxiu YuCarrington Merritt
CollaboratorsECOG: Dr. Haewon ShinSleep Spindles: Dr. Bradley VaughnModeling ECOG: Dr. Jeremy LefebvreElectric Field Spatial Targeting: Dr. Angel PeterchevSCZ Clinical Trial: Dr. Fred Jarskog, Dr. John GilmoreMood Disorders Clinical Trials: Dr. David Rubinow
FundingNIMH BRAINS R01 MH101547, NIMH R21MH105557, NIMH R21MH105574, Human Frontier Science Program, UNC School of Medicine, Department of Psychiatry, NCTraCS(CTSA #1UL1TR001111), Foundation of Hope, UNC SOM TTSA, NARSAD, Tal Medical, Patient Donations.